Therapeutic and clinical foundations of cannabidiol therapy for difficult-to-treat seizures in children and adults with refractory epilepsies
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic and clinical foundations of cannabidiol therapy for difficult-to-treat seizures in children and adults with refractory epilepsies
Authors
Keywords
-
Journal
EXPERIMENTAL NEUROLOGY
Volume 359, Issue -, Pages 114237
Publisher
Elsevier BV
Online
2022-10-04
DOI
10.1016/j.expneurol.2022.114237
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Time to Onset of Cannabidiol (CBD) Treatment Effect and Resolution of Adverse Events in Tuberous Sclerosis Complex: Post Hoc Analysis of Randomized Controlled Phase 3 Trial GWPCARE6
- (2022) Joyce Y. Wu et al. EPILEPSIA
- Methodology for classification and definition of epilepsy syndromes with list of syndromes: Report of the ILAE Task Force on Nosology and Definitions
- (2022) Elaine C. Wirrell et al. EPILEPSIA
- A scoping review on cannabidiol therapy in tuberous sclerosis: Current evidence and perspectives for future development
- (2022) Debopam Samanta EPILEPSY & BEHAVIOR
- Antiseizure Medications for Adults With Epilepsy
- (2022) Andres M. Kanner et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Therapeutic Basis of Generic Substitution of Antiseizure Medications
- (2022) Sarah Elmer et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis
- (2022) Ashna Talwar et al. EXPERIMENTAL NEUROLOGY
- Efficacy of the FDA-approved cannabidiol on the development and persistence of temporal lobe epilepsy and complex focal onset seizures
- (2022) Doodipala Samba Reddy et al. EXPERIMENTAL NEUROLOGY
- Cannabidiol in the treatment of epilepsy: Current evidence and perspectives for further research
- (2021) Valentina Franco et al. NEUROPHARMACOLOGY
- Time to onset of cannabidiol (CBD) treatment effect in Lennox–Gastaut syndrome: Analysis from two randomized controlled trials
- (2021) Michael Privitera et al. EPILEPSIA
- Long-term safety and efficacy of highly purified cannabidiol for treatment refractory epilepsy
- (2021) Tyler E. Gaston et al. EPILEPSY & BEHAVIOR
- Molecular mechanisms of sex differences in epilepsy and seizure susceptibility in chemical, genetic and acquired epileptogenesis
- (2021) Doodipala Samba Reddy et al. NEUROSCIENCE LETTERS
- Cannabidiol modifies the seizure expression and effects of antiseizure drugs in a rat model of recurrent severe seizures
- (2021) Christian Lizette Frías-Soria et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Cannabigerolic acid, a major biosynthetic precursor molecule in cannabis, exhibits divergent effects on seizures in mouse models of epilepsy
- (2021) L. L. Anderson et al. BRITISH JOURNAL OF PHARMACOLOGY
- Add‐on cannabidiol in patients with Dravet syndrome: Results of a long‐term open‐label extension trial
- (2021) Ingrid E. Scheffer et al. EPILEPSIA
- Long‐term safety and efficacy of add‐on cannabidiol in patients with Lennox–Gastaut syndrome: Results of a long‐term open‐label extension trial
- (2021) Anup D. Patel et al. EPILEPSIA
- Time to onset of cannabidiol treatment effects in Dravet syndrome: Analysis from two randomized controlled trials
- (2021) Jennifer Madan Cohen et al. EPILEPSIA
- Long‐term cannabidiol treatment for seizures in patients with tuberous sclerosis complex: An open‐label extension trial
- (2021) Elizabeth A. Thiele et al. EPILEPSIA
- Contusion brain damage in mice for modelling of post-traumatic epilepsy with contralateral hippocampus sclerosis: Comprehensive and longitudinal characterization of spontaneous seizures, neuropathology, and neuropsychiatric comorbidities
- (2021) Victoria M. Golub et al. EXPERIMENTAL NEUROLOGY
- Prevalence, healthcare resource utilization and mortality of Lennox-Gastaut syndrome: retrospective linkage cohort study
- (2021) Richard F.M. Chin et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Efficacy and safety of medical cannabinoids in children: a systematic review and meta-analysis
- (2021) Nir Treves et al. Scientific Reports
- Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome
- (2020) Ian Miller et al. JAMA Neurology
- Does cannabidiol have antiseizure activity independent of its interactions with clobazam? An appraisal of the evidence from randomized controlled trials
- (2020) Meir Bialer et al. EPILEPSIA
- Mechanisms of action of currently used antiseizure drugs
- (2020) Graeme J. Sills et al. NEUROPHARMACOLOGY
- Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials
- (2020) Edward Chesney et al. NEUROPSYCHOPHARMACOLOGY
- Cannabidiol efficacy independent of clobazam: Meta‐analysis of four randomized controlled trials
- (2020) Orrin Devinsky et al. ACTA NEUROLOGICA SCANDINAVICA
- Cannabidiol in conjunction with clobazam: analysis of four randomized controlled trials
- (2020) Boudewijn Gunning et al. ACTA NEUROLOGICA SCANDINAVICA
- Sex Differences in the Epilepsies and Associated Comorbidities: Implications for Use and Development of Pharmacotherapies
- (2020) Catherine A. Christian et al. PHARMACOLOGICAL REVIEWS
- Cannabidiol interactions with voltage-gated sodium channels
- (2020) Lily Goodyer Sait et al. eLife
- Add-On Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex
- (2020) Elizabeth A. Thiele et al. JAMA Neurology
- Long-term safety and efficacy of cannabidiol in children and adults with treatment-resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results
- (2019) Linda C. Laux et al. EPILEPSY RESEARCH
- Evidence of a clinically significant drug‐drug interaction between cannabidiol and tacrolimus
- (2019) Abbie D. Leino et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Cannabinoid therapy in epilepsy
- (2019) Santoshi Billakota et al. CURRENT OPINION IN NEUROLOGY
- Preclinical safety and efficacy of cannabidivarin for early life seizures
- (2019) Megan N. Huizenga et al. NEUROPHARMACOLOGY
- Food effect on pharmacokinetics of cannabidiol oral capsules in adult patients with refractory epilepsy
- (2019) Angela K. Birnbaum et al. EPILEPSIA
- Effects of cannabidiol on brivaracetam plasma levels
- (2019) Kerstin A. Klotz et al. EPILEPSIA
- Higher cannabidiol plasma levels are associated with better seizure response following treatment with a pharmaceutical grade cannabidiol
- (2019) Jerzy P. Szaflarski et al. EPILEPSY & BEHAVIOR
- Synthetic, non-intoxicating 8,9-dihydrocannabidiol for the mitigation of seizures
- (2019) Mark Mascal et al. Scientific Reports
- Cannabidiol Interacts Significantly with Everolimus—Report of a Patient with Tuberous Sclerosis Complex
- (2019) Adelheid Wiemer-Kruel et al. NEUROPEDIATRICS
- Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions
- (2019) Lyndsey L. Anderson et al. EPILEPSIA
- Cannabidiol Elevates Mechanistic Target of Rapamycin Inhibitor Levels in Patients With Tuberous Sclerosis Complex
- (2019) Daniel Ebrahimi-Fakhari et al. PEDIATRIC NEUROLOGY
- Long-term safety and treatment effects of cannabidiol in children and adults with treatment-resistant epilepsies: Expanded access program results
- (2018) Jerzy P. Szaflarski et al. EPILEPSIA
- Management of epilepsy associated with tuberous sclerosis complex: Updated clinical recommendations
- (2018) Paolo Curatolo et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
- (2018) Elizabeth A Thiele et al. LANCET
- Cannabidiol Inhibits Endocannabinoid Signaling in Autaptic Hippocampal Neurons
- (2018) Alex Straiker et al. MOLECULAR PHARMACOLOGY
- Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome
- (2018) Orrin Devinsky et al. NEUROLOGY
- Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome
- (2018) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs
- (2018) Zhibin Chen et al. JAMA Neurology
- Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study
- (2018) Jerzy P. Szaflarski et al. EPILEPSY & BEHAVIOR
- Inhibitory effects of cannabidiol on voltage-dependent sodium currents
- (2018) Mohammad-Reza Ghovanloo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age
- (2018) José A. Crippa et al. Frontiers in Immunology
- A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
- (2018) Lesley Taylor et al. CNS DRUGS
- Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis
- (2018) Simona Lattanzi et al. DRUGS
- Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models
- (2018) Pabitra Hriday Patra et al. EPILEPSIA
- Long-term cannabidiol treatment in patients with Dravet syndrome: An open-label extension trial
- (2018) Orrin Devinsky et al. EPILEPSIA
- Cannabis-based products for pediatric epilepsy: A systematic review
- (2018) Jesse Elliott et al. EPILEPSIA
- Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial
- (2018) Kerri A. Schoedel et al. EPILEPSY & BEHAVIOR
- Anticonvulsant effect of cannabinoid receptor agonists in models of seizures in developing rats
- (2017) Megan N. Huizenga et al. EPILEPSIA
- Dravet syndrome and its mimics: Beyond SCN1A
- (2017) Dora Steel et al. EPILEPSIA
- Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection
- (2017) Evan C. Rosenberg et al. EPILEPSY & BEHAVIOR
- Cannabinoids in treatment-resistant epilepsy: A review
- (2017) Brooke K. O'Connell et al. EPILEPSY & BEHAVIOR
- Evaluation of Cannabidiol in Animal Seizure Models by the Epilepsy Therapy Screening Program (ETSP)
- (2017) Brian D. Klein et al. NEUROCHEMICAL RESEARCH
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- (2017) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABA A receptors
- (2017) T. Bakas et al. PHARMACOLOGICAL RESEARCH
- Epigenetic interventions for epileptogenesis: A new frontier for curing epilepsy
- (2017) Iyan Younus et al. PHARMACOLOGY & THERAPEUTICS
- Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome
- (2017) Joshua S. Kaplan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- From genotype to phenotype in Dravet disease
- (2017) Svetlana Gataullina et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- A resurging boom in new drugs for epilepsy and brain disorders
- (2017) Iyan Younus et al. Expert Review of Clinical Pharmacology
- Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders
- (2017) Alline C. Campos et al. Frontiers in Pharmacology
- Protective Effects of Cannabidiol against Seizures and Neuronal Death in a Rat Model of Mesial Temporal Lobe Epilepsy
- (2017) Raquel A. Do Val-da Silva et al. Frontiers in Pharmacology
- Cannabidiol attenuates OGD/R-induced damage by enhancing mitochondrial bioenergetics and modulating glucose metabolism via pentose-phosphate pathway in hippocampal neurons
- (2017) Shanshan Sun et al. Redox Biology
- Aberrant epilepsy-associated mutant Nav1.6 sodium channel activity can be targeted with cannabidiol
- (2016) Reesha R. Patel et al. BRAIN
- Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex
- (2016) Evan J. Hess et al. EPILEPSIA
- Cannabidiol Post-Treatment Alleviates Rat Epileptic-Related Behaviors and Activates Hippocampal Cell Autophagy Pathway Along with Antioxidant Defense in Chronic Phase of Pilocarpine-Induced Seizure
- (2016) Mahshid Hosseinzadeh et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
- (2016) Orrin Devinsky et al. LANCET NEUROLOGY
- Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus
- (2016) A. Vanessa Stempel et al. NEURON
- Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors
- (2016) Raquel Linge et al. NEUROPHARMACOLOGY
- CBD-enriched medical cannabis for intractable pediatric epilepsy
- (2016) Michal Tzadok et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Dissecting the phenotypes of Dravet syndrome by gene deletion
- (2015) Moran Rubinstein et al. BRAIN
- Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
- (2015) R B Laprairie et al. BRITISH JOURNAL OF PHARMACOLOGY
- Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy
- (2015) Alexandra L. Geffrey et al. EPILEPSIA
- Δ9-Tetrahydrocannabinol alone and combined with cannabidiol mitigate fear memory through reconsolidation disruption
- (2015) Cristina A.J. Stern et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Cannabinoids and Epilepsy
- (2015) Evan C. Rosenberg et al. Neurotherapeutics
- Cannabinoids in the Treatment of Epilepsy
- (2015) Daniel Friedman et al. NEW ENGLAND JOURNAL OF MEDICINE
- The case for medical marijuana in epilepsy
- (2014) Edward Maa et al. EPILEPSIA
- Lennox-Gastaut syndrome: A consensus approach to differential diagnosis
- (2014) Blaise F. D. Bourgeois et al. EPILEPSIA
- Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
- (2014) Orrin Devinsky et al. EPILEPSIA
- Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1receptor-independent mechanism
- (2013) T D M Hill et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol Is a Potent Inhibitor of the Catalytic Activity of Cytochrome P450 2C19
- (2013) Rongrong Jiang et al. Drug Metabolism and Pharmacokinetics
- Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy
- (2013) Brenda E. Porter et al. EPILEPSY & BEHAVIOR
- Experimental Models of Status Epilepticus and Neuronal Injury for Evaluation of Therapeutic Interventions
- (2013) Doodipala Reddy et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cannabidiol Normalizes Caspase 3, Synaptophysin, and Mitochondrial Fission Protein DNM1L Expression Levels in Rats with Brain Iron Overload: Implications for Neuroprotection
- (2013) Vanessa Kappel da Silva et al. MOLECULAR NEUROBIOLOGY
- Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect
- (2013) Marta Solinas et al. PLoS One
- Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses
- (2013) S. Sylantyev et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cannabidivarin is anticonvulsant in mouse and rat
- (2012) AJ Hill et al. BRITISH JOURNAL OF PHARMACOLOGY
- Successful use of fenfluramine as an add-on treatment for Dravet syndrome
- (2012) Berten Ceulemans et al. EPILEPSIA
- Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: Possible involvement of 5HT1A receptors
- (2012) Alline Cristina Campos et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
- (2012) A. C. Campos et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures
- (2012) Nicholas A. Jones et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Marijuana, endocannabinoids, and epilepsy: Potential and challenges for improved therapeutic intervention
- (2011) Mackenzie E. Hofmann et al. EXPERIMENTAL NEUROLOGY
- Effects of intracisternal administration of cannabidiol on the cardiovascular and behavioral responses to acute restraint stress
- (2011) Érica M. Granjeiro et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement
- (2011) Giuseppe Esposito et al. PLoS One
- Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive–compulsive behaviour
- (2011) Serena Deiana et al. PSYCHOPHARMACOLOGY
- Likert scales, levels of measurement and the “laws” of statistics
- (2010) Geoff Norman ADVANCES IN HEALTH SCIENCES EDUCATION
- Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis
- (2010) Susanne A Wolf et al. Cell Communication and Signaling
- Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
- (2010) José Alexandre S Crippa et al. JOURNAL OF PSYCHOPHARMACOLOGY
- International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
- (2010) R. G. Pertwee et al. PHARMACOLOGICAL REVIEWS
- Endogenous cannabinoid signaling is essential for stress adaptation
- (2010) M. N. Hill et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical pharmacokinetic interactions between antiepileptic drugs and hormonal contraceptives
- (2010) Doodipala Samba Reddy Expert Review of Clinical Pharmacology
- Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors
- (2009) TV Zanelati et al. BRITISH JOURNAL OF PHARMACOLOGY
- Regulation of adult neurogenesis by stress, sleep disruption, exercise and inflammation: Implications for depression and antidepressant action☆
- (2009) P.J. Lucassen et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Increased Risk of Death Among Children With Lennox-Gastaut Syndrome and Infantile Spasms
- (2009) Andrew R. Autry et al. JOURNAL OF CHILD NEUROLOGY
- Cannabidiol Displays Antiepileptiform and Antiseizure Properties In Vitro and In Vivo
- (2009) N. A. Jones et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic–ischemic brain damage in mice is mediated by CB2 and adenosine receptors
- (2009) A. Castillo et al. NEUROBIOLOGY OF DISEASE
- Inhibition of Recombinant Human T-type Calcium Channels by Δ9-Tetrahydrocannabinol and Cannabidiol
- (2008) Hamish Redmond Ross et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling
- (2008) J M Bessa et al. MOLECULAR PSYCHIATRY
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now